Monocytes as Gene Therapy Vectors for the Treatment of Alzheimer’s Disease
The accumulation of amyloid-ß; protein (Aß) in Alzheimer's disease (AD) is a well known pathological event. Decreasing the production or increasing the degradation of Aß; is therefore thought to serve as a potential therapeutic intervention in AD. Recent in vitro and in vivo studies have sugges...
Main Author: | Lebson, Lori Ann |
---|---|
Format: | Others |
Published: |
Scholar Commons
2008
|
Subjects: | |
Online Access: | https://scholarcommons.usf.edu/etd/356 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=1355&context=etd |
Similar Items
-
Neprilysin and Aβ-clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer´s disease
by: Marcus O Grimm, et al.
Published: (2013-12-01) -
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
by: Bouter, Yvonne
Published: (2015) -
Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model
by: R. Scherzer-Attali, et al.
Published: (2012-06-01) -
C-terminally truncated Amyloid-β peptides in Alzheimer’s dementia: Deposition of Aβ37, Aβ38, and Aβ39 in the brains of patients with sporadic and familiar Alzheimer’s dementia and in transgenic mouse models.
by: Reinert, Jochim
Published: (2018) -
Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)